Novo Nordisk A/S - Research Update Published: Nov 18, 2008 BAGSVAERD, DENMARK--(Marketwire - November 18, 2008) - FDA reschedules Advisory Committee meeting for liraglutide - no change of review timeline anticipated. Related links BioSpace.com This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news